Addressing Current Questions and Emerging Considerations with the Use of PARP Inhibitors in the Management of Ovarian Cancer

CME Provided by Research to Practice; this symposium is supported by AbbVie Inc., AstraZeneca Pharmaceuticals LP, Clovis Oncology and TESARO. CE is not offered by SGO.

Moderator:

• Neil Love, MD, Research to Practice, Miami, FL
  

Faculty:

• Kathleen N. Moore, MD, University of Oklahoma, Oklahoma City, OK
• Robert L. Coleman, MD, The University of Texas MD Anderson Cancer Center, Houston, TX
• Jonathan Ledermann, MD, UCL Cancer Institute at University College London, London, UK
• Amit M. Oza, MD, University Health Network, Toronto, Canada

Location: Kalakaua A

Registration Link: www.ResearchToPractice.com/Meetings/GynOnc2019